Search company, investor...

Zhihui Medical

Founded Year



Seed VC | Alive

About Zhihui Medical

Zhihui Medical develops CTC detection nanotechnology. Its CTC detection nanotechnology utilizes the biophysical characteristics generated by the metabolic differences of cancer cells to achieve high-sensitivity, high-specificity, broad-spectrum, and even efficient CTC detection. The company was founded in 2018 and is based in Quanzhou, China.

Headquarters Location

No. 105, Area A, Sanchuang Park, No. 3001 South Section of Century Avenue, Luoshan Street, Jinjiang City

Quanzhou, Fujian,


Missing: Zhihui Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Zhihui Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Zhihui Medical Frequently Asked Questions (FAQ)

  • When was Zhihui Medical founded?

    Zhihui Medical was founded in 2018.

  • Where is Zhihui Medical's headquarters?

    Zhihui Medical's headquarters is located at No. 105, Area A, Sanchuang Park, No. 3001, Quanzhou.

  • What is Zhihui Medical's latest funding round?

    Zhihui Medical's latest funding round is Seed VC.

  • Who are the investors of Zhihui Medical?

    Investors of Zhihui Medical include Nantong Blue Bay Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.